- Home
- BTBD vs INM Comparison
BTBD vs INM Comparison
Compare BTBD & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTBD | INM |
|---|---|---|
| Founded | 1987 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 7.7M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTBD | INM |
|---|---|---|
| Price | $1.75 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.9K | ★ 69.7K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,823,472.00 | $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $1.03 | $0.58 |
| 52 Week High | $2.48 | $2.50 |
Technical Indicators
Market Signals| Indicator | BTBD | INM |
|---|---|---|
| Relative Strength Index (RSI) | 76.25 | 43.33 |
| Support Level | $1.53 | $1.03 |
| Resistance Level | $1.67 | $1.40 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 90.91 | 22.86 |
Price Performance
Historical ComparisonAbout BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.